The World Health Organization may add GLP1 drugs to Essential Medicines List
Have petitioned the World Health Organization (WHO) to add GLP1 Receptor Agonists to the list of essential medicines for countries.
We're about to summarize it, but it's easy to read the final application for yourself thanks to the open, collaborative nature of the WHO, you can find the application online (click here).
Recognizing the usefulness of GLP1 Receptor Agonists like Semaglutide (Ozempic, Wegovy, Rybelsus) and Tirzepatide (Mounjaro, Zepbound) means more countries are going to focus on trying to boost production and create more of the drugs.
While we don't know if the WHO will accept the application, it's impressive that it is being suggested, and inclusion could be a sea change in recognition of GLP1 drugs and their benefits.
The World Health Organization maintains lists of "essential" medicines, in fact there's a great article published on PubMed in which you can read about it:
The application also recommends the combination of Liraglutide with decrease in eating and exercise, and notes that the eventual weight loss is likely to be within 4-5%:
